| Literature DB >> 23056929 |
Shelly N Hester1, Deborah S Hustead, Amy D Mackey, Atul Singhal, Barbara J Marriage.
Abstract
Faster weight gain early in infancy may contribute to a greater risk of later obesity in formula-fed compared to breast-fed infants. One potential explanation for the difference in weight gain is higher macronutrient intake in formula-fed infants during the first weeks of life. A systematic review was conducted using Medline to assess the macronutrient and energy content plus volume of intake in breast-fed and formula-fed infants in early infancy. All studies from healthy, term, singleton infants reporting values for the composition of breast milk during the first month of life were included. The energy content of colostrum (mean, SEM: 53.6 ± 2.5 kcal/100 mL), transitional milk (57.7 ± 4.2 kcal/100 mL), and mature milk (65.2 ± 1.1 kcal/100 mL) was lower than conventional infant formula (67 kcal/100 mL) on all days analyzed. The protein concentration of colostrum (2.5 ± 0.2 g/100 mL) and transitional milk (1.7 ± 0.1 g/100 mL) was higher than formula (1.4 g/100 mL), while the protein content of mature milk (1.3 ± 0.1 g/100 mL) was slightly lower. Formula-fed infants consume a higher volume and more energy dense milk in early life leading to faster growth which could potentially program a greater risk of long-term obesity.Entities:
Year: 2012 PMID: 23056929 PMCID: PMC3463945 DOI: 10.1155/2012/891201
Source DB: PubMed Journal: J Nutr Metab ISSN: 2090-0724
Checklist for reporting systemic reviews, using the meta-analysis of observational studies in epidemiology [17].
| Background: definition of the problem | (i) Limited information on the macronutrient and energy content of human breast milk |
| (ii) Hypothesized infant formula may be too energy dense for infants during the first weeks | |
|
| |
| Search strategy | (i) Searched Medline database from inception until early 2011 |
| (ii) Hand-search relevant journals and references from identified studies | |
| (iii) Contact authors if additional information was needed to complete meta-analysis above | |
|
| |
| Inclusion and exclusion criteria | (i) Study included if healthy, term, singleton infants reporting values during the first month |
| (ii) Breast milk and infant formula daily intake values analyzed were for either exclusively | |
| (iii) Only studies which reported new data were included, and duplicate publications (e.g., in reviews) were excluded | |
|
| |
| Methods | (i) Only studies that used valid methods were included, but no formal assessment of quality |
|
| |
| Results | (i) Give results of individual studies (in tables) and group estimates (in tables and text) |
| (ii) Essential details of methodology and sample for each study included (in tables) | |
|
| |
| Discussion/conclusion | (i) Give generalization of the conclusions |
| (ii) Need for further research | |
*All data was based on published studies with the exception of one dataset on intake of formula-fed infants [18].
Lipid concentration in breast milk (g/100 mL).
| Study | Colostrum | Transition | Mature >14 days* |
| Population |
|---|---|---|---|---|---|
| [ | 4.7 ± 0.4 | 13 | USA | ||
| [ | 1.9 ± 0.4 | 2.9 ± 0.2 | 3.1 ± 0.2 | 10 | Canada |
| [ | 1.0 ± 0.2 | 2.7 ± 0.4 | 4.3 ± 0.4 | 13,11,12 | St. Lucia |
| [ | 2.5 ± 0.3 | 4.1 ± 0.2 | 10,29 | Venezuela | |
| [ | 2.8 ± 0.2 | 69 | Italy | ||
| [ | 4.9 ± 0.3 | 13 | USA | ||
| [ | 4.0 ± 0.3 | 12 | USA | ||
| [ | 1.7 ± 0.2 | 3.5 ± 0.4 | 3.9 ± 0.5 | 10,12,12 | USA |
| [ | 3.0 ± 0.1 | 3.6 ± 0.2 | 192,14 | Japan | |
| [ | 1.8 ± 0.3 | 3.8 ± 0.2 | 3.9 ± 0.2 | 18,22,23 | USA |
| [ | 4.1 ± 0.1 | 71 | Australia | ||
| [ | 2.5 ± 0.1 | 3.5 ± 0.2 | 65,64 | Peru | |
| [ | 4.0 ± 0.1 | 34 | Australia | ||
| [ | 2.0 ± 0.1 | 2.5 ± 0.1 | 2.8 ± 0.1 | 41 | India |
| [ | 2.6 ± 0.4 | 3.3 ± 0.1 | 7,24 | Switzerland | |
| [ | 3.1 ± 0.1 | 3.5 ± 0.1 | 48,46 | Finland | |
| [ | 3.6 ± 0.2 | 52 | Italy | ||
| [ | 2.5 ± 0.7 | 3.3 ± 0.4 | 3.2 ± 0.6 | 3,5, 5 | Netherlands |
| [ | 4.0 ± 0.0 | 52 | North China | ||
| [ | 2.7 ± 0.2 | 2.8 ± 0.2 | 3.9 ± 0.2 | 21,39,40 | Japan |
| Meta-analysis results | 2.2 ± 0.2 | 3.0 ± 0.1 | 3.8 ± 0.1 |
Reported as mean ± SEM.
*Mature milk > 14 days and <6 weeks.
Carbohydrate concentration in breast milk (g/100 mL).
| Study | Colostrum 1–5 days | Transition | Mature |
| Population |
|---|---|---|---|---|---|
| [ | 6.4 ± 0.0 | 13 | USA | ||
| [ | 5.1 ± 0.2 | 5.9 ± 0.2 | 6.5 ± 0.2 | 10 | Canada |
| [ | 2.6 ± 0.0 | 4.1 ± 0.0 | 9 | Australia | |
| [ | 7.6 ± 0.3 | 8.3 ± 0.2 | 10,29 | Venezuela | |
| [ | 6.4 ± 0.2 | 19 | USA | ||
| [ | 5.6 ± 0.1 | 6.3 ± 0.1 | 6.4 ± 0.1 | 46 | Italy |
| [ | 7.1 ± 0.2 | 13 | USA | ||
| [ | 6.3 ± 0.2 | 12 | USA | ||
| [ | 6.1 ± 0.1 | 6.8 ± 0.2 | 7.1 ± 0.2 | 10,13,12 | USA |
| [ | 5.5 ± 0.1 | 6.5 ± 0.1 | 77,47 | Australia | |
| [ | 5.9 ± 0.2 | 7.0 ± 0.2 | 15,11 | Sweden | |
| [ | 5.1 ± 0.9 | 6.4 ± 0.4 | 65,63 | Peru | |
| [ | 6.0 ± 0.1 | 18 | Australia | ||
| [ | 7.3 ± 0.2 | 7 | USA | ||
| [ | 5.2 ± 0.1 | 4.6 ± 0.1 | 5.0 ± 0.2 | 41 | India |
| [ | 5.8 ± 0.1 | 6.7 ± 0.1 | 6.9 ± 0.1 | 24,24,22 | USA |
| [ | 7.5 ± 0.1 | 7.7 ± 0.1 | 48,46 | Finland | |
| [ | 7.6 ± 0.2 | 41 | North China | ||
| [ | 5.8 ± 0.4 | 5.8 ± 0.2 | 6.4 ± 0.3 | 3,5, 5 | Netherlands |
| [ | 5.2 ± 0.1 | 6.2 ± 0.0 | 7,10 | France | |
| [ | 6.0 ± 0.1 | 6.0 ± 0.1 | 5.9 ± 0.1 | 21,39,40 | Japan |
| Meta-analysis results | 5.6 ± 0.6 | 5.9 ± 0.4 | 6.7 ± 0.2 |
Reported as Mean ± SEM.
*Mature milk > 14 days and <6 weeks.
Protein concentration in breast milk (g/100 mL).
| Study | Colostrum | Transition | Mature |
| Population |
|---|---|---|---|---|---|
| [ | 1.2 ± 0.1 | 13 | USA | ||
| [ | 3.0 ± 0.2 | 1.2 ± 0.1 | 10,29 | Venezuela | |
| [ | 6.5 ± 0.7 | 15 | Taiwan | ||
| [ | 1.9 ± 0.0 | 69 | Italy | ||
| [ | 1.4 ± 0.1 | 16 | Australia | ||
| [ | 3.8 ± 1.5 | 1.7 ± 0.1 | 0.9 ± 0.1 | 8,3, 6 | USA |
| [ | 1.4 ± 0.1 | 13 | USA | ||
| [ | 2.3 ± 0.1 | 1.6 ± 0.1 | 1.5 ± 0.1 | 12,13,12 | USA |
| [ | 2.2 ± 0.1 | 1.4 ± 0.1 | 192,14 | Japan | |
| [ | 1.6 ± 0.1 | 0.9 ± 0.1 | 15 | Sweden | |
| [ | 2.4 ± 0.1 | 1.3 ± 0.1 | 0.8 ± 0.0 | 3,4, 7 | USA |
| [ | 3.0 ± 0.2 | 1.6 ± 0.0 | 62,59 | Peru | |
| [ | 1.1 ± 0.0 | 18 | Australia | ||
| [ | 1.8 ± 0.1 | 7 | USA | ||
| [ | 1.9 ± 0.1 | 1.6 ± 0.1 | 1.3 ± 0.1 | 41 | India |
| [ | 3.5 ± 0.2 | 2.5 ± 0.2 | 2.1 ± 0.2 | 22,24,21 | USA |
| [ | 2.0 ± 0.0 | 1.5 ± 0.0 | 48,46 | Finland | |
| [ | 1.8 ± 0.1 | 1.4 ± 0.0 | 1.3 ± 0.1 | 28,47,28 | Spain |
| [ | 1.2 ± 0.0 | 41 | North China | ||
| [ | 3.1 ± 1.3 | 1.8 ± 0.0 | 1.4 ± 0.1 | 3,5, 5 | Netherlands |
| [ | 1.8 ± 0.1 | 1.9 ± 0.1 | 1.7 ± 0.0 | 21,39,40 | Japan |
| Meta-analysis results | 2.5 ± 0.2 | 1.7 ± 0.1 | 1.3 ± 0.1 |
Reported as mean ± SEM.
*Mature milk > 14 days and <6 weeks.
Studies reporting infant breast milk intake.
| Study | Method | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 7 | >14 days* |
| Population |
|---|---|---|---|---|---|---|---|---|---|---|
| [ | TW* | 717 ± 37 | 13 | USA | ||||||
| [ | TW | 384 ± 45 | 500 ± 59 | 10, 7 | Canada | |||||
| [ | TW | 728 ± 21 | 37 | USA | ||||||
| [ | TW | 752 ± 38 | 20 | USA | ||||||
| [ | TW | 710 ± 70 | 10 | USA | ||||||
| [ | TW | 39 ± 14 | 120 ± 21 | 294 ± 43 | 420 ± 46 | 465 ± 26 | 11 | USA | ||
| [ | TW | 539 ± 42 | 743 ± 44 | 19 | USA | |||||
| [ | ISO** | 891 ± 23 | 20 | UK | ||||||
| [ | TW | 664 ± 38 | 15 | Netherlands | ||||||
| [ | TW | 673 ± 53 | 13 | USA | ||||||
| [ | TW | 31 ± 9 | 42 ± 10 | 15 | Israel | |||||
| [ | TW | 21 ± 5 | 88 ± 8 | 231 ± 13 | 371 ± 14 | 430 ± 16 | 452 ± 14 | 26 (d1) 88 (d2–7) | Australia | |
| [ | ISO | 802 ± 57 | 10 | UK | ||||||
| [ | TW | 582 ± 14 | 71 | USA | ||||||
| [ | TW | 558 ± 21 | 724 ± 35 | 15, 11 | Sweden | |||||
| [ | TW | 758 ± 26 | 35 | Denmark | ||||||
| [ | TW | 416 ± 24 | 34 | Australia | ||||||
| [ | TW | 611 ± 41 | 7 | USA | ||||||
| [ | TW | 818 ± 49 | 10 | USA | ||||||
| [ | TW | 43 ± 28 | 177 ± 28 | 360 ± 47 | 437 ± 54 | 483 ± 38 | 556 ± 61 | 633 ± 50 | 6, 9, 10, 10, 11, 7, 9 | USA |
| [ | TW | 441 ± 29 | 489 ± 35 | 22 | USA | |||||
| [ | TW | 600 ± 48 | 11 | USA | ||||||
| [ | TW | 15 ± 1 | 90 | Brazil | ||||||
| [ | TW | 671 ± 30 | 16 | Netherlands | ||||||
| [ | TW | 671 ± 43 | 17 | USA | ||||||
| Meta-analysis results |
|
|
|
|
|
|
|
Reported as mean ± SEM.
*TW: test weighing method.
**IS: isotopic method.
Studies reporting infant formula intake.
| Study | Day 1** | Day 2** | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | >14 days* |
| Population |
|---|---|---|---|---|---|---|---|---|---|---|
| [ | 856.0 ± 41.4 | 10 | USA | |||||||
| [ | 845.0 ± 26.9 | 18 | USA | |||||||
| [ | 732.2 ± 29.5 | 12 | Netherlands | |||||||
| [ | 61.1 ± 6.0 | 139.3 ± 8.9 | 28 | Israel | ||||||
| [ | 755.0 ± 21.0 | 45 | USA, Canada | |||||||
| [ | 190.8 ± 8.3 | 297.4 ± 11.9 | 410 ± 11 | 495 ± 12 | 538 ± 13 | 560 ± 14 | 568 ± 14 | d1–3 = 100, d4-5 = 99, | UK | |
| [ | 724.5 ± 28.0 | 12 | USA | |||||||
| [ | 765.3 ± 42.3 | 10 | USA | |||||||
| [ | 267.6 ± 28.9 | 361.9 ± 24.2 | 412 ± 26 | 493 ± 32 | 566 ± 30 | 555 ± 27 | 576 ± 29 | 696.8 ± 30.8 | 29 | |
| Meta-analysis results |
|
|
|
Reported as mean ± SEM.
All intakes were calculated using bottle weighing method.
*Mature milk > 14 days and <6 weeks.
**Meta-analysis was only done where there are at least 3 studies for given day.
Metabolizable energy content of breast milk1.
| Study | Colostrum | Transition | Mature | Method |
| Population |
|---|---|---|---|---|---|---|
| [ | 72.7 ± 13.8 | Calculated | 13 | USA | ||
| [ | 45.1 ± 16.5 | 56.5 ± 10.2 | Calculated | 10 | Canada | |
| [ | 63.4 ± 1.0** | Calculated | 37 | USA | ||
| [ | 63.2 ± 1.8** | Bomb calorimetry | 10 | USA | ||
| [ | 64.9 ± 4.4 | 74.9 ± 2.5 | Calculated | 10,29 | Venezuela | |
| [ | 78.2 ± 3.5 | Calculated | 13 | USA | ||
| [ | 63.7 ± 2.6** | Bomb calorimetry | 12 | USA | ||
| [ | 67.1±1.7 | Bomb calorimetry | 10 | USA | ||
| [ | 48.9 ± 9.2 | 65.1 ± 16.2 | 69.5±18.7 | Calculated | 10,12,12 | USA |
| [ | 54.8 ± 0.5 | 61.6 ± 0.9** | Bomb calorimetry | 227 | Japan | |
| [ | 61.9 ± 7.4** | Bomb calorimetry | 11 | Canada | ||
| [ | 61.3 ± 17.7** | Doubly labeled water | 12 | UK | ||
| [ | 54.9 ± 16.5 | 63.5 ± 16.5** | Calculated | 65,63 | Peru | |
| [ | 64.0 ± 7.4** | Calculated | 18 | Australia | ||
| [ | 46.4 ± 1.5 | 47.3 ± 1.9 | 50.4 ± 2.0** | Calculated | 41,41,41 | India |
| [ | 68.5 ± 3.8 | Calculated | 25 | USA | ||
| [ | 65.8 ± 1.8 | 67.8 ± 1.8 | Calculated | 48,46 | Finland | |
| [ | 67.6 ± 3.1 | Calculated | 41 | North China | ||
| [ | 58.1 ± 13.2 | 60.1 ± 5.1 | 60.0 ± 6.7** | Calculated | 3,5, 5 | Netherlands |
| [ | 65.0 ± 0.5** | Calculated | 415 (milk bank donors) | USA | ||
| [ | 65.4 ± 2.2** | Bomb calorimetry | 8 | USA | ||
| [ | 53.9 ± 2.8 | 56.8 ± 2.2 | 65.9 ± 2.6** | Calculated | 21,39,40 | Japan |
| Meta-analysis results | 53.6 ± 2.5 | 57.7 ± 4.2 | 65.2 ± 1.1 |
Reported as mean ± SEM.
1Gross energy content of breast milk was converted into metabolizable energy (ME) levels by multiplying the classic Atwater factors 4, 4, 9 kcal/g for carbohydrate, protein, and lipid, respectively, and by assuming 93% of gross breast milk energy reported by bomb calorimetry methods is metabolizable.
*Mature milk > 14 days and <6 weeks.
** Indicates value below current infant formula level 67.0 kcal/100 mL.